Cargando…
Shikonin improves pulmonary vascular remodeling in monocrotaline‑induced pulmonary arterial hypertension via regulation of PKM2
Pulmonary arterial hypertension (PAH), a fatal disease with an insidious onset and rapid progression, shows characteristics such as increases in pulmonary circulatory resistance and pulmonary arterial pressure, and progressive right heart failure. Shikonin can reduce right ventricular systolic press...
Autores principales: | Li, Wenfeng, Chen, Wenjuan, Peng, Hongyan, Xiao, Zhenghui, Liu, Jinqiao, Zeng, Yunhong, Huang, Ting, Song, Qingqing, Wang, Xun, Xiao, Yunbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936259/ https://www.ncbi.nlm.nih.gov/pubmed/36734266 http://dx.doi.org/10.3892/mmr.2023.12947 |
Ejemplares similares
-
Integrated analysis of m(6)A mRNA methylation in rats with monocrotaline-induced pulmonary arterial hypertension
por: Zeng, Yunhong, et al.
Publicado: (2021) -
Evaluation of right ventricular longitudinal strain in pediatric patients with pulmonary hypertension by two-dimensional speckle-tracking echocardiography
por: Liu, Qianjun, et al.
Publicado: (2023) -
Comprehensive analysis of m(6)A methylomes in idiopathic pulmonary arterial hypertension
por: Huang, Ting, et al.
Publicado: (2023) -
Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
por: Cai, Changhong, et al.
Publicado: (2019) -
Ligation of patent ductus venosus in a child with pulmonary arterial hypertension and hypersplenism: A case report
por: Xiao, Yunbin, et al.
Publicado: (2020)